4 weeks Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of “Moderate Buy” by BrokeragesMarketBeat
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received an average rating of “Moderate Buy” from the ten brokerages that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a…
X